The introduction of Retatrutide ZPHC, at a strength of 120mg, is sparking considerable excitement within the weight loss community. This novel dual GIP and GLP-1 receptor medication suggests to offer significant improvements in weight reduction compared to previous therapies. Initial clinical dat